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1684-1182/Copyright ª 2014, Taiwan S
BY-NC-ND license (http://creativecomBackground: A rotavirus outbreak in a neonatal intensive care unit (NICU) may have cata-
strophic consequences for young infants receiving critical care. From May 13, 2011 to July
11, 2011, a significant increase in stool samples testing positive for rotavirus antigens in the
NICU of a university affiliated hospital was observed. Due to lack of clinical presentations sug-
gestive of rotavirus infection in the patients and the rarity of rotavirus infection in the NICU in
the past, a pseudo-outbreak was suspected.
Methods: Infection control measures were reinforced initially. To investigate the outbreak, a
prospective laboratory-based active surveillance of all infants in the NICU was conducted right
after the cluster was identified. Repeated testing using a modified enzyme immunoassay (EIA)
kit, rotavirus RNA polyacrylamide gel electrophoresis (PAGE), reverse transcription polymerase
chain reaction (RT-PCR), and retrospective chart review methods were used to confirm the
pseudo-outbreak.
Results: Seven infants in the NICU, with or without gastrointestinal symptoms, tested positive
for the rotavirus antigen using the old version of an EIA kit, which indicated a possible
outbreak. Active surveillance with repeated tests for recollected stool samples using a modi-
fied EIA kit showed negative results in all 24 infants in the NICU. Seven stored stool samplest of Pediatrics, National Taiwan University Hospital, Number 8, Chung Shan South Road, Zhongzheng
w (C.-Y. Lu), lmhuang@ntu.edu.tw (L.-M. Huang).
.08.030
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mons.org/licenses/by-nc-nd/4.0/).
948 B.F. Tan et al.from four infants, which previously tested positive for the rotavirus antigen, tested negative
for rotavirus using the modified EIA kit, PAGE, and RT-PCR. Chart reviews showed no clinical
difference between index cases and controls. False positivity might arise from unsatisfactory
specificity of the old EIA kit. After the introduction of the modified EIA kit, no rotavirus was
detected in the NICU for at least 7 months.
Conclusion: This cluster of patients who tested positive for the rotavirus antigen in stools was
confirmed to be a pseudo-outbreak. Interpretation of the old EIA for rotavirus in an NICU
setting should be done with caution until the mechanism of the false-positive reaction is eluci-
dated.
Copyright ª 2014, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).Introduction
Rotavirus is one of the leading causes of gastroenteritis in
young children and infants, including nosocomial infections
in neonates.1e3 Young infants are especially susceptible to
rotavirus infections. In one of our previous studies, 40% of
nosocomial rotavirus infections occurred in children
younger than 6 months of age.4 Although neonatal rotavirus
infections can be mild or asymptomatic,5e7 life-threatening
events such as necrotizing enterocolitis and secondary
bacteremia may develop as well.8e10 Diagnosis of rotavirus
infection in neonates or infants is relatively difficult, as
atypical clinical manifestations, such as bradycardia or
apnea,11 in addition to the gastrointestinal symptoms, may
be present. Hence, a rapid and effective laboratory test is
necessary for diagnosis. In the 1970s and early 1980s, the
electron microscope served as an important tool for diag-
nosis of rotavirus infections,12 however, most hospitals now
use the immunoassay methods. Despite advancements in
diagnostic tools, limitations still exist and sometimes cause
unexpected events such as pseudo-outbreaks when false-
positives occur in clusters.
Herein, we describe a pseudo-outbreak of a rotavirus
infection in the neonatal intensive care unit (NICU) at Na-
tional Taiwan University Hospital (NTUH). Rotavirus out-
breaks in the NICU have been rare in the past. However,
stool samples from seven infants tested positive for rota-
virus within 2 months, from May 13, 2011 to July 11, 2011.
Several infection control measures and investigations were
implemented. After further testing, this situation was
determined to be a pseudo-outbreak.Methods
Hospital setting and study population
NTUH is a 2500-bed, university-affiliated teaching hospital
and medical center in Northern Taiwan. The NICU contains
25 beds including one isolation room, and is located in the
children’s hospital at NTUH. The NICU provides both pri-
mary and tertiary care for severely sick neonates and young
infants. Most of the patients at NTUH were born locally, but
some were transferred from other hospitals or nursery
settings. Prospective, hospital-wide nosocomial infectionsurveillance has been conducted since 1981. Standard
precautions are strictly executed by healthcare personnel
in the NICU as a daily practice.
Cases and definitions
Data from stool samples tested with enzyme immunoassay
(EIA) for rotavirus between January 2007 and February 2012
were extracted from the virology database at NTUH.
Monthly distributions of positive and negative samples were
further analyzed. The monthly positive rate for rotavirus is
defined as the number of positive rotavirus tests from stool
specimens divided by the number of all specimens sub-
mitted in the corresponding month. The mean monthly
positive rate in the past 5 years was used as the baseline
rotavirus positive rate. The epidemic threshold is defined as
the baseline rotavirus positive rate plus two standard de-
viations. Outbreak is defined as when the rotavirus positive
rate exceeds the epidemic threshold for 2 consecutive
months. Pseudo-outbreak is a condition when an apparent
cluster of infection is subsequently shown to be artifactual.
It may be caused by inadequate processing or contamina-
tion of specimens, laboratory errors, or changes in sur-
veillance techniques.13
The infants who tested positive during the outbreak
period were defined as index cases, while all the remaining
patients in the NICU were defined as the controls.
Infection control measures
The infection control measures conducted during the
outbreak period included reinforcement of existing hygiene
measures, implementation of additional infection control
measures, and execution of active surveillance.
The initial infection control reinforcement emphasized
the importance and the execution of hand hygiene, as
previously described.14 Besides, every infant who tested
positive for the rotavirus was under strict contact isolation
and cohort care. Visitors and healthcare workers in the
NICU were firmly required to follow standard precautions.
Stringent infection control methods targeting rotavirus
transmissions were implemented. In addition to hand
washing, visitors were required to wear a mask and gown
before entering the NICU. Environmental and terminal
disinfections were performed thoroughly, especially in the
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index infants stayed. Medical devices, such as the probes of
the sonogram machine, were disinfected with 0.06% sodium
hypochlorite after every use. Additional measures were
applied to feeding procedures in order to prevent fecal-oral
transmission. Feeding bottles and orogastric tubes were
well-sterilized, pacifiers were rinsed with hot water, new
feeding syringes were replaced before every feeding, and
nursing sets were individualized. Nurses were requested to
discard used diapers and excrement in a proper way.
Infection committee personnel visited the NICU periodically
to evaluate the execution of the aforementioned infection
control measures.
Active surveillance was aimed at prospectively identi-
fying rotavirus infections. It started right after the identi-
fication of the cluster of cases. This included laboratory
screening of all young infants staying in the NICU during the
defined outbreak period, using the recollected stool sam-
ples. Additional tests were performed on particular stored
stool samples. The methods used are described below.Rotavirus detection and confirmation
The stool specimens were tested by EIA for the qualitative
determination of the rotavirus antigen (RIDASCREEN Rota-
virus, R-Biopharm AG, Darmstadt, Germany) by staff in the
virology section of the central laboratory at NTUH, which
met the requirements for internal and external quality
control of the Proficiency Test and was accredited by the
College of American Pathologists (CAP). This CAP accredi-
tation is renewed every 2 years. The test uses monoclonal
antibodies against VP6, a protein of the inner capsid of the
rotavirus. This commercial kit was reported to exhibit
sensitivity of 100%, specificity of 99.73%, a positive pre-
dictive value of 93.74%, and a negative predictive value of
100%.15 The reagents were stored at a temperature of 4C
as required. The temperature of the refrigerator was
continuously monitored. The shelf-life, storage conditions
(including the temperature and humidity), and the expira-
tion date of the kit were checked every month by the
laboratory personnel. All technicians were well trained.
The stool specimens were suspended to approximately
10% in sample dilution buffer and centrifuged at 2500  g
for 5 minutes. The remaining suspensions were stored at
20C after initial testing. Two drops (100 mL) of conjugate
were added into the microwell with the fecal suspension
and mixed. Next, the mixture was incubated at room
temperature (20e25C) for 60 minutes, and then washed
five times with a washing buffer. Afterwards, two drops of
substrate were added, mixed, and then incubated at room
temperature (20e25C) in the dark for 15 minutes. Then,
one drop of stop reagent was added and mixed. Finally, the
optical density was measured photometrically at 450 nm.
Regarding quality control, positive and negative control
samples were used each time the test was carried out. The
extinction (optical density) for the negative control was <
0.2 at 450 nm and the measured value for the positive
control was > 0.8 at 450 nm. If the value was > 0.2 for the
negative control, insufficient washing was likely, and the
washing steps were corrected. If the values differed from
the required values, or if the substrate was turbid or hadturned blue before it was added to the wells, then it was
possible that the reagents had expired and would not be
used. If the stipulated values were not met, the following
points would be checked before repeating the test: expiry
date of the reagents used, functionality of the equipment
being used (e.g., calibration), correct test procedure,
contamination or leaks of the kit components, and
abnormal appearance (e.g., turned blue) of the substrate
solution.16
Before July 27, 2011, the test was examined using the old
protocol (denoted as old EIA kit) where only one conjugate
was used. Starting fromJuly 27, 2011, the old EIAmethodwas
replaced by a new modified protocol (denoted as modified
EIA kit). The two kits differ in the steps of adding the con-
jugate(s). The old EIA kit added peroxidase-conjugated
mouse monoclonal antirotavirus antibodies together with
the sample. Whereas the modified EIA kit added conjugates
in two steps, first adding biotinylated monoclonal anti-
rotavirus antibodies together with the sample, and after a
washing step, adding streptavidin-conjugated peroxidase.
This change may be related to the improvement of speci-
ficity.16 The modified EIA kit applied during the active sur-
veillance was performed by the independent laboratory at
the Center for Infection Control, NTUH.
Molecular detection of the rotavirus was performed in
particular stool samples by the laboratory of the Depart-
ment of Clinical Laboratory Sciences and Medical Biotech-
nology, College of Medicine, National Taiwan University.
Rotavirus RNA was extracted with phenol-chloroform and
further purified with guanidine thiocyanate-silicon diox-
ide.17 Polyacrylamide gel electrophoresis (PAGE) of
extracted rotavirus RNA product was performed using
reference strain DS-1 and Wa as positive controls. The
rotavirus VP7, VP4, VP6, and NSP4 genes were amplified by
reverse transcription polymerase chain reaction (RT-PCR)
using DS-1 as a positive control. The primers were described
previously.17e20
Clinical information and statistical analysis
Medical charts were reviewed retrospectively after the
outbreak. Demographic, clinical, and laboratory data were
collected. Data from the index and control cases were
compared using the Fisher’s exact test for categorical
variables and the Mann-Whitney U test for continuous var-
iables. A p value of < 0.05 was considered significant. All
statistical operations were two-tailed and performed with
SPSS version 19.0 (SPSS Inc., Chicago, IL, USA).
Results
Fig. 1A shows the number of stool samples which tested
positive for rotavirus at the NICU from January 2007 to
February 2012. Rotavirus infection in the NICU from 2007 to
the first half of 2010 was rare and occurred sporadically.
Cases increased in the second half of 2010 and peaked from
February to July of 2011. Meanwhile, the number of stool
samples which tested positive for rotavirus in other units of
NTUH (excluding those in the NICU) showed characteristics
of seasonality (Figure 1B). The number peaked around
February to May in most years.
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Figure 1. Monthly distribution of stool samples tested for rotavirus in the A. neonatal intensive care unit (NICU) and B. at
National Taiwan University Hospital (NTUH) excluding the NICU from January 2007 to February 2012.
950 B.F. Tan et al.After rotavirus infection was identified in three cases in
February and one in March 2011, the NICU staff were
required to reinforce contact precautions and hand hygiene
practices. In April, there was no rotavirus detected in the
NICU. However, from May 13, 2011 to July 11, 2011, seven
infants in the NICU tested positive for rotavirus in their
stool samples. These cases had gastrointestinal symptoms
such as blood tinged stool, abdominal distension or feeding
intolerance. Due to the high alertness of the clinicians,
checkup of stool samples from closely neighbored patients
who had no symptoms or only nonspecific symptoms were
done. Surprisingly, the tests revealed positive results in a
portion of patients. Repeated tests were then performed
for stool samples from the seven patients which gave 21
(47%) positive results in 45 samples (Table 1). Rotavirus EIA
was performed frequently in the NICU from May to July of
2011. A total of 56 stool samples were tested within this
period, comprising 33% of the total 172 tests performed in
the NICU from year 2007 to 2011. During this period of time,
the positive rates of detection in May and June achieved25%, respectively, which exceed the epidemic threshold of
the corresponding months (21% in May and 22% in June) and
indicated a potential outbreak.
The unexpected increase of rotavirus infections in the
NICU attracted special attention from the infection control
committee of NTUH. Infection control measures were re-
emphasized and an outbreak investigation was carried out.
First of all, active surveillance was conducted. Stool
samples from all 24 patients in the NICU, including the
seven index cases, were screened for rotavirus from July
14, 2011 to July 19, 2011. These tests were examined by an
independent laboratory supervised by the infection control
committee using the modified EIA kit, instead of the old EIA
kit used previously. All 24 screening tests revealed negative
results. Additional studies were performed on the seven
stored stool samples from four infants which previously
tested positive using the old EIA kit. On July 26, 2011 these
stored stool samples were rechecked using the modified EIA
kit and all were negative. For further confirmation, the
same seven stored stool samples were further tested by
Table 1 Laboratory tests performed and their results for index cases
Index
case
Age at the
time of
detection (d)
Sex
(M/F)
GA at
birth
(wk)
Symptoms Relative
date a
Positive old
EIA/number
tested
Positive
modified
EIA/number
tested b
Positive RT-PCR/
number performed c
1 53 M 25 Bloody stool Day 1 4/4 0/1 NA
2 20 F 27 Abdominal distension,
gastroesophageal reflux
Day 21 9/14 0/1 0/4
3 62 M 29 Abdominal distension Day 22 2/11 0/1 NA
4 30 F 24 Abdominal distension Day 46 1/4 0/1 0/1
5 5 M 29 Ileus, abdominal distension Day 46 2/5 0/1 0/1
6 13 M 26 Abdominal distension Day 53 2/4 0/1 0/1
7 18 M 31 Abdominal distension,
feeding intolerance
Day 60 1/3 0/1 NA
Total 21/45 0/7 0/7
a Relative date of the first positive EIA report for each index case.
b The tests were performed on recollected stool by an independent laboratory from the infection control committee.
c RT-PCR was performed on previous old EIA-positive stored stool samples by an independent laboratory at the Department of Lab-
oratory Medicine, National Taiwan University.
Cases are listed in a sequence of the date of the first positive stool rotavirus enzyme immunoassay (EIA) during the pseudo-outbreak
period (May 13, 2011eJuly 11, 2011).
EIA Z enzyme immunoassay; GA Z gestational age; NA Z not applicable; RT-PCR Z reverse transcription polymerase chain reaction.
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similar bands on the gel compared with the positive con-
trols, indicating no detectable rotavirus genomic RNA from
these stool samples. RT-PCR aimed at detecting VP7, VP4,
VP6 and NSP4 genes were all negative (Table 1).
The central laboratory then changed the stool detection
method from using the old EIA kit to the modified EIA kit
after July 27, 2011. Since then, there have still been some
detectable rotavirus infections in other units at NTUH but
not in the NICU.
Table 2 shows the demographics and clinical manifesta-
tions of the seven index cases and 17 controls. Comparisons
of the laboratory data were also made between the index
cases and controls (Table 3). There were no statistically
significant differences in the demography except signifi-
cantly younger postmenstrual age, lower birth weight, and
lower body weight in the index case group. The clinical
features between these two groups, including the common
clinical manifestations of rotavirus infection, and possible
protective and risk factors, were not significantly different.
In the laboratory data, two groups showed no difference in
hemogram, liver enzymes, renal function, electrolytes, C-
reactive protein, and stool examinations. The only differ-
ence was hemoglobin, which was lower in the index group.
Three index cases and 14 controls were taking premature or
regular infant formulas. Some cases were taking the
following oral medication while their stools tested positive
for rotavirus: metoclopramide (8 cases), theophylline (6
cases), ferric hydroxide (5 cases), furosemide (1 case),
kaolin/pectin (1 case), and sildenafil citrate (1 case).
Discussion
Using the modified EIA kit for the fresh and stored stool
samples, RT-PCR for the stored stool samples, and the
clinical data analysis, we concluded that the increasedrotavirus infections in the NICU was a pseudo-outbreak.
Pseudo-outbreaks often become apparent when inconsis-
tency exists between clinical, epidemiological, and labo-
ratory findings. Mitigation requires collaboration between
clinical, laboratory, and public health personnel.13 This
event was first suspected as a pseudo-outbreak mainly due
to two reasons. First, most patients did not have typical
clinical symptoms and signs, which are presumed to be
present in young children. Second, a cluster of rotavirus
infections has rarely been detected in the NICU in the past.
Comparison of rotavirus infections in the NICU and other
units over 5 years (Fig. 1A and B) showed that rotavirus
infections in the NICU were unique in that they were mainly
sporadic without any seasonality. Our study of rotavirus
infections in neonatal intermediate ICUs in the past was
consistent with this finding.2 This is explained by the fact
that the NICU is a relatively isolated environment with
stricter infection control practices. Most patients in the
NICU were neonates or small infants who were born pre-
maturely in the hospital. They experienced very limited
community exposure, if any. In true NICU outbreaks,
nosocomial transmission plays a major role. In units other
than the NICU, the trend is similar to other temperate
countries where rotavirus infection is common in the winter
and early spring.21 Our study results suggest the cluster of
positive cases at the NICU was attributed to decreased
specificity of the EIA kit and frequent stool testing in a
given, short period of time. Decreased specificity directly
increases the number of false-positive results, decreases
the positive predictive value of the test, and increases the
perceived incidence of infection.22 Repeated testing in-
creases the number of false-positive results, with false-
positive results greatly outnumbering true-positive results.
After realizing the increase of positive rotavirus results
was actually a pseudo-outbreak, the central laboratory of
the hospital introduced a newer modified EIA kit. It applies
Table 2 Comparison of demographics and clinical features between index cases and controls a
Total (n Z 24) Index (n Z 7) Control (n Z 17) p
Demographics
Postnatal age (d) 36.2  40.1
(0w161)
28.7  21.2
(5w62)
39.2  46
(0w161)
0.727
Postmenstrual age (wk) 36 1/7  6
(28 3/7w53 4/7)
32  3 4/7
(28 3/7w38 1/7)
37 6/7  6
(30 4/7w53 4/7)
0.013
Gestational age (wk) 31  5 4/7
(22 6/7w41 2/7)
27 6/7  2 4/7
(24 1/7w31 6/7)
32 2/7  6
(22 6/7w41 2/7)
0.152
Birth weight (g) 1513  1009
(496w3800)
701  178
(496w910)
1847  1022
(528w3800)
0.008
Vaginal delivery 5 (21%) 2 (29%) 3 (18%) 0.608
Male patients 17 (71%) 5 (71%) 12 (71%) 1.000
Weight (g) 1861  1128
(430w4530)
778  254
(430w1072)
2307  1001
(856w4530)
0.000
Hospitalization period (d) 35  40 (1w162) 30  21 (6w63) 37  46 (1w162) 0.494
Underlying disease 17 (71%) 6 (86%) 11 (65%) 0.625
Clinical features
Unstable vital signs 4 (16.7%) 1 (14%) 3 (18%) 1.000
Emesis 2 (8.3%) 0 (0%) 2 (12%) 1.000
Feeding intolerance 3 (12.5%) 1 (14%) 2 (12%) 1.000
Abdominal distension 12 (50%) 6 (86%) 6 (35%) 0.069
Bloody stool 1 (4.2%) 1 (14%) 0 (0%) 0.292
Defecation frequency (/d) 3.1  2.7 (0w10) 2.3  2.1 (0w6) 3.5  2.9 (0w10) 0.300
Stool amount (g/kg/d) 6.2  5.1 (0w20.6) 6.7  6 (0w17.8) 6.1  4.9 (0w20.6) 0.799
Abdominal surgery 2 (8%) 0 (0%) 2 (12%) 1.000
NG tube/OG tube
prior 7 days
23 (96%) 7 (100%) 16 (94%) 1.000
NPO status 7 (29%) 4 (57%) 3 (18%) 1.134
Breast milk feeding 12 (50%) 3 (43%) 9 (53%) 1.000
Feeding amount
(mL/kg/d)
54  65 (0w179) 35  61 (0w150) 61  67 (0w179) 0.164
Oral drug use 8 (33%) 2 (29%) 6 (35%) 1.000
Parenteral nutrition 16 (67%) 7 (100%) 9 (53%) 0.054
Parenteral antibiotic 10 (42%) 3 (43%) 7 (41%) 1.000
a Please see text for the definitions of index cases and controls.
NG Z Nasogastric; NPO Z Nil per os; OG Z Orogastric.
952 B.F. Tan et al.two antibody conjugates in the procedures to increase the
specificity of the test. The true reason why performances of
these two kits differed remained unclear, because we did
not test the same stool specimens using the same method
(e.g., old EIA kit) by two different laboratories at the same
time. However, by using modified EIA as well as molecular
and clinical analysis, we have clearly demonstrated the
initial results from the central lab were not good.
After this event, rotavirus stool testing was still ongoing
in clinically suspicious cases, but arbitrary tests were being
discouraged and restricted. There was no further detection
of rotavirus in the NICU for at least 7 months after July
2011. Continuous surveillance is implemented to monitor
the performance of the new modified EIA method as well as
rotavirus infections in the NICU and other units at NTUH.
There was a time interval between the first positive
stool samples using the old EIA test and the negative
confirmation using the modified EIA test on recollected
fresh stool samples. One may question the duration of viral
shedding in stool after infection. Previous studies have
shown that rotavirus shedding in neonates is longer when
compared to children and may extend up to 75 dayspostinfection.7,23 In our cases, the time interval mentioned
was shorter, with a mean of 28 days and a median of 21
days. In addition, we also used RT-PCR, a sensitive method
which was able to detect low copy numbers of rotavirus
RNA. The performance of the modified EIA test, especially
false-negative results, was not of major concern, as true
rotavirus infections were still detectable in other settings
at NTUH using the modified EIA.
Quality control procedures are needed to ensure that
different laboratories are performing the commercial assay
at high proficiency.24 The virology section of the central
laboratory at NTUH fulfilled the requirements for internal
and external quality control of the proficiency test by the
CAP. The section processed all samples sent from all set-
tings at NTUH but false-positive results were only found in
the NICU samples. We believe that flaws in infection control
and laboratory processes were less likely to be the cause of
positivity in rotavirus detection.
False-positivity of immunoassay detection methods for
stool samples has been described previously.25-27 Faden
et al28 reported an adenovirus gastroenteritis pseudo-
outbreak in an NICU. The cause of false-positive results
Table 3 Comparison of laboratory data between index cases and controls a
Number of
samples (n)
Total Index Control p
Hemoglobin (g/dL) 22 13.2  2.7 (9w18.8) 11  1.7 (9w13.5) 14.1  2.6 (9.7w18.8) 0.016
Platelets (K/mL) 22 263.7  125.7 (38w575) 211  103.3 (38w335) 283.4  130.4 (61w575) 0.284
WBC (K/mL) 22 11.1  4.1 (3w18.4) 11.3  4.8 (3w17) 11.1  4 (5w18.4) 0.658
AST (U/L) 12 59.8  56.7 (12w192) 53.5  71.8 (12w161) 63  53 (29w192) 0.124
ALT (U/L) 13 18.2  11.5 (4w42) 16.8  17 (6w42) 18.8  9.5 (4w32) 0.486
Blood urine nitrogen
(mg/dL)
14 9.3  4.6 (2w16.7) 12.1  4.2 (6.9w16.7) 8.2  4.5 (2w15) 0.157
Serum creatinine
(mg/dL)
16 0.6  0.2 (0.4w1.2) 0.6  0.2 (0.4w0.8) 0.7  0.3 (0.4w1.2) 0.820
Sodium (mmol/L) 18 135.9  3.7 (127w143) 134.2  6.2 (127w143) 136.6  2.3 (133w140) 0.297
Potassium (mmol/L) 17 4.6  0.7 (3.6w5.6) 4.2  0.6 (3.6w5.1) 4.7  0.6 (3.7w5.6) 0.153
C-reactive protein
(mg/dL)
19 0.9  1.7 (0w5.7) 0.3  0.5 (0w1.2) 1.1  1.9 (0w5.7) 0.255
Stool occult blood 10 7 (70%) 4 (80%) 3 (60%) 1.000
Stool pus cell 5 1 (20%) 1 (33%) 0 (0%) 1.000
Positive stool culture 3 0 (0%) 0 (0%) 0 (0%)
a Please see text for the definitions of index cases and controls.
ALT Z alanine aminotransferase; AST Z aspartate aminotransferase; WBC Z white blood cell.
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amounts of protein A of Staphylococcus aureus in the
specimen has never been reported as a possible cause.29
Hence, it is reasonable to suspect undetermined inter-
fering substances in the stool in our cases as a possible
cause of false positivity. Most of our patients were fed with
breast milk or infant formula and some oral medications
were used. Occult blood was detected in the stool of some
cases. Among the seven index cases, three received stool
cultures for Salmonella, Shigella, Campylobacter, and
Clostridium difficile. All yielded negative results.
False-positive results might have biased the clinicians’
clinical judgment. The index cases were frequently regar-
ded as symptomatic solely due to abdominal distension.
Index cases had significantly younger postmenstrual ages
and lower weights than the controls. They were more
eventful than controls, which misled clinicians to suspect
rotavirus infection and further perform EIA on these pa-
tients. The lower hemoglobin in index cases also can be
explained by the fact that they were at a higher risk for
anemia of prematurity and may have more frequent blood
samplings, due to unstable clinical conditions. Comparison
of index cases and controls in the current study did not
show any difference in clinical symptoms between them.
These results further support that the index cases were not
truly infected by rotavirus.
The pseudo-outbreak carried certain negative impacts.
Several studies have shown that patients who are placed in
contact precautions are less likely to receive complete vital
signs recording and examination.30e32 In addition, they are
at increased risk if they cohort with those truly infected by
rotavirus. Although this did not really happen in our case,
we still took the precautions before all the cohorted pa-
tients proved to be false-positive. During a pseudo-
outbreak, patients would probably receive excessive ex-
amination and treatment.13 Unnecessary infection preven-
tion measures increase the burden upon healthcare
providers and utilization of hospital administrativeresources and are not cost-beneficial. It also results in a
lack of confidence in the credibility of the laboratory.13
Psychologically, this pseudo-outbreak also created worry
and anxiety among parents. More or less, this has weakened
the rapport between the parents and healthcare providers
and may further affect the image of the hospital.
There are several limitations in this study. First, the
retrospective chart review confers an imperfect follow up
and collection of data. Although the performance of the
modified EIA could be challenged, theoretically it would
show higher specificity using two antibody conjugates
instead of one during the test procedures. Finally, we did
not identify the etiology in this pseudo-outbreak, although
unknown content in the stool was highly suspected to be
the cause of the false-positivity.
In conclusion, we described a pseudo-outbreak of a
rotavirus infection in an NICU at a tertiary-care hospital.
Comparison between index cases and controls, modified
EIA, PAGE, and RT-PCR methods confirmed the false-
positivity of the EIA formerly used. Detection of rotavirus
in the NICU is a serious occurrence that requires immediate
and thorough investigation. The methods used to detect
rotavirus must be reliable. Any test with an unsatisfactory
specificity should not be used in the NICU. Despite an EIA kit
with higher specificity being substituted, interpretation of
all positive results should be done with caution until the
mechanism of the false-positive reaction is elucidated.Conflicts of interest
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